To hear about similar clinical trials, please enter your email below
Trial Title:
Dermatoscopy Guided Resection for Skin Cancer
NCT ID:
NCT06342297
Condition:
Basal Cell Carcinoma
Cutaneous Squamous Cell Carcinoma
Surgical Margin
Conditions: Official terms:
Carcinoma
Carcinoma, Squamous Cell
Carcinoma, Basal Cell
Conditions: Keywords:
Dermatoscopy
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Treatment
Masking:
Single (Outcomes Assessor)
Intervention:
Intervention type:
Device
Intervention name:
Dermatoscopy
Description:
Dermatoscopy used in decision of surgical margin before resection of basal cell carcinoma
or cutaneous squamous cell carcinoma
Arm group label:
Dermatoscopy
Summary:
In this randomizid controlled trial the aim is to use dermatoscopy in deciding the
resection margin for patients with suspected or verified basal cell carcinoma or
cutaneous squamous cell carcinoma. The outcome is radical/non radical resection of the
lateral margins in the pathology report.
Detailed description:
In basal cell carcinoma and especially cutaneous squamous cell carcinoma the prognosis is
very good if the tumour is radically removed in the primary resection. In this study we
propose that the use of dermatoscopy in deciding the surgical margins can increase the
proportion of radically removed tumours. In this randomized clinical trial the use of
dermatoscopy in deciding the surgical margins in patients with suspected or verified
basal cell carcinoma or cutaneous squamous cell carcinoma is assessed. The outcome
measure is radical/non radical resection of the lateral margins. In the control group
dematoscopy is not used in deciding the surgical margin. 400 patients with suspected or
verified BCC or cSCC will be included, 200 in each group.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Patients with primary suspected or verified basal cell carcinoma or cutaneous cell
carcinoma
Exclusion Criteria:
- Recurrent tumours
- Previous radiotherapy of the tumour area
- If the patient cannot understand the study i nformation
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Örebro University Hospital
Address:
City:
Örebro
Zip:
70375
Country:
Sweden
Status:
Recruiting
Contact:
Last name:
Örebro U Hospital
Phone:
0729655663
Email:
fredrik.landstrom@regionorebrolan.se
Start date:
January 14, 2024
Completion date:
January 14, 2026
Lead sponsor:
Agency:
Region Örebro County
Agency class:
Other
Source:
Region Örebro County
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06342297
